Dominick J Angiolillo - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Dominick J Angiolillo

Showing results (531-540 of 761) with videos related to

Pageof 77

Sort By:

Journal of the American College of Cardiology|March 26, 2016

Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: The CRUSH StudyFabiana Rollini, Francesco Franchi, Jenny Hu, et al.

Journal of the American College of Cardiology|May 5, 2012

Pharmacodynamic effects of prasugrel dosing regimens in patients on maintenance prasugrel therapy: results of a prospective randomized studyAntonio Tello-Montoliu, Salvatore D Tomasello, José Luis Ferreiro, et al.

Clinical Cardiology|December 12, 2024

Rationale and Design of a Study to Assess the Engagement and Usefulness of the Care4Today Connect Digital Health Application for Disease Management in Coronary Artery Disease and Peripheral Artery Disease (iPACE-CVD Study)Dhanunjaya Lakkireddy, Dominick J Angiolillo, Kristofer Charlton-Ouw, et al.

JACC. Cardiovascular Interventions|August 5, 2019

Effects of Methylnaltrexone on Ticagrelor-Induced Antiplatelet Effects in Coronary Artery Disease Patients Treated With MorphineFrancesco Franchi, Fabiana Rollini, Yongwhi Park, et al.

Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 21, 2016

Relationship between diabetes, platelet reactivity, and the SYNTAX score to one-year clinical outcome in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary interventionStefano De Servi, Gabriele Crimi, Paolo Calabrò, et al.

Journal of the American College of Cardiology|September 2, 2025

Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,592 patientsMattia Galli, Stefano Benenati, Claudio Laudani, et al.

Journal of the American College of Cardiology|October 8, 2021

Bridging Antiplatelet Therapy After Percutaneous Coronary Intervention: JACC Review Topic of the WeekAlexander E Sullivan, Michael G Nanna, Tracy Y Wang, et al.

International Journal of Cardiology|October 20, 2022

Revascularization strategies versus optimal medical therapy in chronic coronary syndrome: A network meta-analysisMattia Galli, Stefano Benenati, Andrea Zito, et al.

Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 21, 2009

Strategies for drug-eluting stent treatment of bifurcation coronary artery disease in the United States: insights from the e-Cypher S.T.L.L.R.trialNobuaki Suzuki, Dominick J Angiolillo, Mark A Tannenbaum, et al.

European Heart Journal|July 15, 2025

Artificial intelligence in cardiovascular pharmacotherapy: applications and perspectivesFrancesco Costa, Juan Jose Gomez Doblas, Arancha Díaz Expósito, et al.

Pageof 77

Search research articles

Showing results (531-540 of 761) with videos related to

Sort By:

Pageof 77

Journal of the American College of Cardiology|March 26, 2016

Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: The CRUSH StudyFabiana Rollini, Francesco Franchi, Jenny Hu, et al.

Journal of the American College of Cardiology|May 5, 2012

Clinical Cardiology|December 12, 2024

JACC. Cardiovascular Interventions|August 5, 2019

Effects of Methylnaltrexone on Ticagrelor-Induced Antiplatelet Effects in Coronary Artery Disease Patients Treated With MorphineFrancesco Franchi, Fabiana Rollini, Yongwhi Park, et al.

Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 21, 2016

Journal of the American College of Cardiology|September 2, 2025

Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,592 patientsMattia Galli, Stefano Benenati, Claudio Laudani, et al.

Journal of the American College of Cardiology|October 8, 2021

Bridging Antiplatelet Therapy After Percutaneous Coronary Intervention: JACC Review Topic of the WeekAlexander E Sullivan, Michael G Nanna, Tracy Y Wang, et al.

International Journal of Cardiology|October 20, 2022

Revascularization strategies versus optimal medical therapy in chronic coronary syndrome: A network meta-analysisMattia Galli, Stefano Benenati, Andrea Zito, et al.

Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 21, 2009

European Heart Journal|July 15, 2025

Artificial intelligence in cardiovascular pharmacotherapy: applications and perspectivesFrancesco Costa, Juan Jose Gomez Doblas, Arancha Díaz Expósito, et al.

Pageof 77